We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,237.00
Bid: 1,236.00
Ask: 1,238.00
Change: 11.00 (0.90%)
Spread: 2.00 (0.162%)
Open: 1,230.00
High: 1,243.00
Low: 1,230.00
Prev. Close: 1,226.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Senior appointments at Hiscox

8 Feb 2018 09:00

RNS Number : 2927E
Hiscox Ltd
08 February 2018
 

 

 

 

 

 

Senior appointments at Hiscox

 

Hamilton, Bermuda (8 February 2018) - Hiscox Ltd (LSE: HSX) today announces two senior appointments, subject to regulatory and immigration approvals, as the Group evolves its management structure to build on growth momentum in its retail businesses.

 

Ben Walter, CEO of Hiscox USA, will relocate to London to take up the newly created role of CEO Hiscox Global Retail, with effect from 1 July 2018. Ben will lead the Group's retail operations, including Hiscox UK & Ireland, Hiscox Europe, Hiscox USA and Hiscox Special Risks. Ben will focus on driving product innovation and growth across the Group's retail operations, where Hiscox sees plenty of opportunity.

 

Steve Langan, CEO of Hiscox UK & Europe, will relocate to New York to take up the role of CEO Hiscox USA, also effective from 1 July 2018. Continuing to build the Hiscox brand and presence in the US market will be critical to its success. Steve will focus on driving Hiscox USA's next phase of growth, drawing on his experience of building retail brands around the world, both at Hiscox and previously at Diageo and Coca Cola. Steve will also remain Chief Marketing Officer for the Group.

 

Bronek Masojada, Hiscox Group Chief Executive Officer, commented: "Hiscox's growth in retail markets, particularly over the last 10 years, has changed the shape of our business. We are no longer a Lloyd's player with retail operations on the side, and as our business evolves we need to be able to respond to the huge opportunity ahead.

 

"Our retail businesses span 12 countries and are at different stages of their journey, but they share similar challenges and opportunities such as brand building, leveraging scale and digitisation. These appointments will help us continue on our path of building a Group which can thrive at all stages of the insurance cycle."

 

Both Ben and Steve will remain on the Executive Committee and Hiscox will begin the process of recruiting a new UK & Ireland CEO in the autumn.

 

 

ENDS

 

For further information:

Hiscox Ltd

Marc Wetherhill, Group Company Secretary +1 441 278 8321

Kylie O'Connor, Head of Communications +44 (0) 20 7448 6656

 

Brunswick

Tom Burns +44 (0)20 7404 5959

Simone Selzer +44 (0)20 7404 5959

 

 

 

 

 

 

 

 

Notes to editors

 

About Ben Walter

 

Ben Walter is Chief Executive Officer of Hiscox USA, the global specialist's US division, which offers a wide range of specialty commercial products. He has led the business for the past five years as it experienced consistent high growth and achieved profitability.

 

Ben joined Hiscox in early 2011 from BlackRock where he was a Managing Director for the asset manager. Prior to that, he held roles at Gap Inc., the Boston Consulting Group, and Continental Airlines.

 

Ben has an MBA from Northwestern's Kellogg School of Management and a BA from Washington University in St. Louis.

 

About Steve Langan

Steve Langan joined Hiscox in 2005 after a highly successful marketing and management career with Diageo, Coca-Cola, Nestlé and Bass Brewers in the UK, Europe and South America.

As MD of Hiscox UK & Ireland, Steve transformed the UK business from a name only known in the City to the UK's most trusted general insurer and a nationally known and respected brand. Over the past three years the Hiscox brand has been successfully launched in the USA and France under his leadership.

Since 2013, Steve has led the UK & Ireland and Europe businesses as a combined entity and from 2014-7 he was also CEO of the Direct Asia Group following its acquisition.

Prior to joining Hiscox Steve worked at the world's number one drinks company Diageo, where he held the position of Managing Director of the company's Italian subsidiary, based in Turin, for three years. He has also held senior marketing and commercial positions with Diageo Ireland and The Coca Cola Company.

Steve is a history graduate of Glasgow University and a Fellow of the Marketing Society.

 

About The Hiscox Group

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. It's a long-standing strategy which in 2016 helped generate gross premiums written of £2,402.6 million and a record profit before tax of £354.5 million.

 

The Hiscox Group employs over 2,700 people in 14 countries, and has customers worldwide. Through the retail businesses in the UK, Europe, Asia and the US, we offer a range of specialist insurance for professionals and business customers as well as homeowners. Internationally traded, bigger ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

 

Our values define our business, with a focus on people, quality, courage and excellence in execution. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPAPEDAPEEF
Date   Source Headline
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202412:17 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20245:15 pmRNSAdditional Listing
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20244:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:16 pmRNSTotal Voting Rights
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202411:30 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20243:37 pmRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20242:06 pmRNSNotice of 2024 AGM and 2023 Annual Report
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:30 amRNSSyndicates 33 and 6104 – results and estimates
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:01 amRNSAnnouncement of share repurchase programme
5th Mar 20247:00 amRNSFull Year Results
19th Feb 20245:48 pmRNSTR-1 Standard form-notification major shareholding
1st Feb 20244:34 pmRNSTotal Voting Rights
8th Jan 20243:07 pmRNSTotal Voting Rights
12th Dec 20234:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.